Channels - Estimated Cost of Adverse Event Management in Treatment Naïve Non-small Cell Lung Cancer Patients with Common EGFR Mutations Treated with Amivantamab Plus Lazertinib and Osimertinib Plus Chemotherapy

Similar Items: Estimated Cost of Adverse Event Management in Treatment Naïve Non-small Cell Lung Cancer Patients with Common EGFR Mutations Treated with Amivantamab Plus Lazertinib and Osimertinib Plus Chemotherapy

Quick Look
Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
Quick Look
COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
Quick Look
Estimating the human development impacts and economic returns from an adolescent cash ‘plus’ programme in Kenya: An economic modelling study
Quick Look
Acquired BRAF-AGK Fusion Following Osimertinib Plus Savolitinib in EGFR-Mutated MET-Amplified Non-Small-Cell Lung Cancer: Durable Response to Gefitinib and Trametinib in a Case Report
Quick Look
Interpretable Dynamic MRI-ITH Model for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer: A Multicenter Study
Quick Look
An examination of adversity and the unique mental health needs of Black crossover immigrant and refugee youth (IRY)
Quick Look
Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
Quick Look
Gender Differences in the Association Between Adverse Childhood Experiences and Drug Use: Findings From a Community-Based Survey in China
Quick Look
Analysis of The Relationship between Blood Groups and Lung Cancer Risk Depending on Histology
Quick Look
Impact of COVID‐19 on Subsequent Lung Function in Childhood: A Systematized Review
Quick Look
Athletic Intervention After Thoracic Surgery for Lung Cancer: Rationale and Design of the ATHENA Study
Quick Look
A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in Spain
Quick Look
Lung Function Decline Among Nonsmoking Adults With Periodontitis in Pakistan: A Cross‐Sectional Study
Quick Look
Within-Provider Variation in Prices for Commonly Utilized Services in Office Setting: Cross-Sectional Study
Quick Look
Correction to “MicroRNA 15a and 16 Regulate Proteostasis in Non‐Small Cell Lung Cancer”
Quick Look
Employment status, occupational profile, and common mental disorders among workers in urban informal settlements in Brazil
Quick Look
Building the foundation: Training, stakeholder engagement, and planning for Common Elements Treatment Approach (CETA) implementation in Uganda
Quick Look
Emerging Novel SARS‐CoV‐2 Subvariants and the Advantages of AI‐ML in Deciphering the Mutation Trends, Genomic Surveillance and Vaccine Development
Quick Look
The New England 4G framework for the treatment of a common health concerns: a gambling case analysis
Quick Look
Association Between Low Chinese Visceral Adiposity Index Values and Chronic Lung Disease in Older Adults: Cohort Study
Quick Look
Causes of the Tendency to Use Common Traditional Therapies Among Older People in Miandoab, Iran: A Cross‐Sectional Study
Quick Look
Reported Effectiveness of a Text‐Based Post‐Operative Care Intervention After Voluntary Medical Male Circumcision (VMMC) to Improve Quality of Care and Adverse Events Identification in Sub‐Saharan Africa: A Scoping Review
Quick Look
MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib‐Resistant MET‐Amplified, EGFR‐Mutated Non‐Small Cell Lung Cancer
Quick Look
Prevalence of Cystic Fibrosis and Pattern of Lung Function Impairment in Adults Presenting With Bronchiectasis at a Tertiary Care Hospital in Resource Poor Country Bangladesh: A Cross‐Sectional Study